Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mesothelioma × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Breast Neoplasms 54 Prostatic Neoplasms 43 Neoplasm Metastasis 24 Multiple Myeloma 24 Osteoporosis 14 Pain 13 Carcinoma, Non-Small-Cell Lung 9 Neoplasms 8 Osteosarcoma 7 Lung Neoplasms 7 Carcinoma, Renal Cell 6 Neuroblastoma 5 Neoplasms, Plasma Cell 5 Humoral Hypercalcemia Of Malignancy 5 Fractures, Bone 4 Bone Diseases, Metabolic 4 Sarcoma, Ewing 3 Sarcoma 3 Lymphoma 3 Kidney Neoplasms 3 Bone Neoplasms 3 Bone Diseases 3 Uterine Cervical Neoplasms 2 Spinal Cord Compression 2 Small Cell Lung Carcinoma 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Ovarian Neoplasms 2 Osteonecrosis 2

Interventions

Pemetrexed 34 Cisplatin 28 pembrolizumab 19 Nivolumab 15 Carboplatin 15 Ipilimumab 11 Gemcitabine 9 Cyclophosphamide 7 durvalumab 6 fludarabine 5 Bevacizumab 5 Radiotherapy, Intensity-Modulated 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 olaparib 3 niraparib 3 anetumab ravtansine 3 Vinorelbine 3 Paclitaxel 3 LMB-100 3 Imatinib Mesylate 3 Cerebral Decortication 3 sargramostim 2 fludarabine phosphate 2 defactinib 2 budigalimab 2 belinostat 2 atezolizumab 2 Vorinostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01204203 2017-05-24

UAB0901

University of Alabama at Birmingham

Phase 2 Completed

8 enrolled 5 charts

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡